Cervical Cancer Drugs Market: Rising Demand and Emerging Trends And Future Opportunities Till 2027

-
Cervical Cancer Drugs
Cervical Cancer Drugs

Cervical cancer develops in the cervix of women and primarily affects sexually active women aged 30 to 45. Cervical cancer frequently has no symptoms in its early stages. However, the death rate from cervical cancer can be significantly reduced by using the Pap test (Papanicolaou test), a screening procedure that can detect changes in the cervix before cancer develops. Cervical cancer comes in several forms, the most common of which are squamous cell cancer and adenocarcinoma.

Drivers of the Cervical Cancer Drugs Market

The increasing number of drug approvals for the treatment of cervical cancer by the U.S. Food and Drug Administration (FDA) is expected to drive Growth in The Cervical Cancer Drugs Market over the forecast period. For example, in September 2017, the FDA approved Mvasi (bevacizumab-awwb) as a biosimilar to Avastin (bevacizumab) for the treatment of multiple cancers, including cervical, lung, brain, colorectal, and kidney cancer. Mvasi is approved for the treatment of persistent, recurrent, or metastatic cervical cancer. The US Food and Drug Administration approved Genentech's Avastin, a bevacizumab solution for intravenous infusion in combination with paclitaxel for the treatment of persistent, recurrent, or metastatic cervical cancer, in August 2014.

Furthermore, rising insurance coverage and an increase in the number of new targeted cancer drugs are expected to support the revenue growth of the Cervical Cancer Drugs Market. For example, the National Cancer Institute spent approximately $4,480 million in 2015 on cancer research, including cervical cancer, lung cancer, colorectal cancer, liver cancer, breast cancer, leukaemia, ovarian cancer, and uterine cancer. Furthermore, according to the American Cancer Society, the United States spent approximately US$ 87.8 billion in 2014 on cancer research, with private insurance companies bearing the majority of the cost (approximately 44 percent).

The rising incidence of cervical cancer in the global population, as well as the rise in the incidence of HIV in women and a lack of awareness about the diagnosis and prevention of invasive cancer, are expected to drive the growth of the Cervical Cancer Drugs Market. Furthermore, in March 2018, the American Cancer Society funded approximately 22 grants for cervical cancer, totaling approximately US$ 9.3 million. The funding value is offered to a single or group of research projects that include a specific type of cancer or cancer area. For example, according to Cancer Research UK data from 2015, approximately 3,200 new cervical cancer cases were registered in the UK each year from 2013 to 2015.

Comments

Post a Comment

Popular posts from this blog

Security Robot Market to Reach US$ 11.8 Billion by 2022

-
Image
Security Robot Market The Global Security Robot Market is estimated to be valued at US$ 11.8 billion in 2022 and is expected to exhibit a CAGR of 12.87% over the forecast period 2022 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Security robots are rapidly gaining traction due to their ability to enhance security and surveillance in various industries. These robots offer advantages such as round-the-clock monitoring, real-time video monitoring, and quick response to potential threats. The increasing need for advanced security measures to prevent theft, vandalism, and unauthorized access is driving the demand for security robots. These robots are widely used in industries such as retail, healthcare, transportation, and manufacturing to ensure the safety of assets and individuals. The market is expected to witness significant growth due to the rising security concerns and advancements in robotic technologies. Market Key Trends: One ke
Read more

Intravenous Fluid Therapy is the Fastest Growing Segment Fueling the Growth of Intravenous Solutions Market

-
Image
Intravenous Solutions Market The global Intravenous Solutions Market is estimated to be valued at US$ 577,228 bn or Million in 2023 and is expected to exhibit a CAGR of 6.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Intravenous solutions are fluids administered through a vein via a needle or catheter. They are often used to provide essential nutrients, medications, or fluids to patients. Common uses include rehydration, correcting electrolyte imbalances, and ensuring nutrition is delivered for patients who cannot eat or absorb nutrients through the digestive system. Market key trends: One of the major trends in the intravenous solutions market is the increasing use of intravenous fluid therapy. Intravenous fluid therapy involves the administration of aqueous solutions containing electrolytes, sugars, and medications through an intravenous catheter. It is widely used for rehydration, maintenance of f
Read more

Global Report on LED Driver Market for the Forecast Period 2023-2030

-
Image
LED Driver Market The LED Driver Market has been growing rapidly over the past few years, driven by the increasing demand for energy-efficient lighting solutions across residential, commercial, and industrial sectors. LED (light-emitting diode) lighting technology has several advantages over traditional lighting solutions such as incandescent and fluorescent lights, including longer lifespan, lower energy consumption, and lower maintenance costs. However, to power and control LED lights, an LED driver is required. The LED Driver Market was valued at USD 7.7 billion in 2020 and is expected to reach USD 10.5 billion by 2025, at a CAGR of 6.4% during the forecast period. LED drivers are electronic devices that regulate the power supply to LED lights. They convert AC voltage from a power source to DC voltage suitable for LEDs, and also provide the necessary current and voltage regulation to ensure proper functioning of the LED lights. LED drivers can be either constant current or constant
Read more